For more than 125 years, Boehringer Ingelheim has been committed to the research and development of innovative medicines that help improve the lives of patients and their families.
Boehringer Ingelheim ranks among the world’s 20 leading pharmaceutical corporations. Our vision drives us forward. It helps us to foster value through innovation in our company and to look to the future with constantly renewed commitment and ambition.
On a monthly-basis, this six-part digital series will delve into perspectives from patients, caregivers and leaders from across the healthcare industry to address changing implications for empathetic care.